First study of the safety, tolerability, and pharmacokinetics of CP-724,714 in patients with advanced malignant solid HER2-expressing tumors.

Source:http://linkedlifedata.com/resource/pubmed/id/17317835

Clin. Cancer Res. 2007 Feb 15 13 4 1238-45

Download in:

View as

Triples

General Info

PMID
17317835